You are now leaving the altogetheryou.co.nz website. This link will take you to a website to which our Privacy Policy does not apply and which may not comply with the New Zealand regulatory requirements. Novartis is not responsible for your interactions with that website. Further information relevant to the New Zealand environment is available from Novartis Medical Information.
Leave website
Cosentyx belongs to a group of medicines called ‘biologic therapies’.
Biologic therapies contain antibodies made from living organisms and are used to treat a number of conditions. The antibody, or active substance in Cosentyx, is secukinumab.
Cosentyx is used to treat the following autoimmune conditions:
In autoimmune diseases – like psoriatic disease, ankylosing spondylitis and non-radiographic axial spondyloarthritis – the immune system mistakenly attacks the body’s own healthy tissues, triggering an increase in inflammation.
What is IL-17A and why is it important?
IL-17A (interleukin-17A) is a substance produced by the immune system.
It usually plays an important role to protect your health. However, high levels in people with autoimmune diseases can cause more inflammation, which results in more severe symptoms.
By reducing the amount of IL-17A in the body, you may be able to reduce the inflammation – and that’s where Cosentyx comes in!
0800 267 368
